Stoke Therapeutics
STOK
STOK
100 hedge funds and large institutions have $495M invested in Stoke Therapeutics in 2023 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 42 increasing their positions, 27 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
4.47% more ownership
Funds ownership: 100.86% → 105.33% (+4.5%)
4% more funds holding
Funds holding: 96 → 100 (+4)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
100
Holding in Top 10
3
Calls
$3.03M
Puts
$177K
Top Buyers
| 1 | +$5.05M | |
| 2 | +$4.76M | |
| 3 | +$4.7M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.8M |
| 5 |
Millennium Management
New York
|
+$3.06M |
Top Sellers
| 1 | -$2.02M | |
| 2 | -$1.98M | |
| 3 | -$1.56M | |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$1.18M |
| 5 |
JPMorgan Chase & Co
New York
|
-$971K |